Kinesiophobia, Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKirsehir Ahi Evran Universitesi
About this trial
The aim of our study was to investigate the relationship between kinesiophobia and pain, balance, physical performance, quality of life and mental status in patients receiving hemodialysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with end stage renal disease receiving hemodialysis
Receiving hemodialysis for more than 3 months
Being clinically stable
Volunteering to participate in this stud
Disqualifiers
None
Trial population
Patients with end-stage renal disease receiving hemodialysis will be enrolled in the study.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
32 Participants
are grouped into 1 trial groupGroup A: Hemodialysis patients
Trial outcomes
Primary outcomes
1
Kinesiophobia
It will be evaluated with the Tampa Kinesiophobia scale.The total score ranges from 17-68, with a score above 37 indicating a high degree of kinesiophobia.
Time frame
Day 12
Pain
Will be evaluated with a numeric rating scale. Higher scores indicate worse outcomes.
Time frame
Day 13
Balance
It will be assessed with a timed up and go test
Time frame
Day 14
Physical performance
It will be evaluated with five-repetition sit-to-stand test
Time frame
Day 1Secondary outcomes
1
Quality of life
It will be evaluated with the Short Form-36 Quality of Life scale.The subscales rate health from 0 to 100, with 0 indicating poor health and 100 indicating good health.
Time frame
Day 12
Mental health
It will be assessed using the Hospital Anxiety and Depression scale. The lowest score they can get from both subscales is 0 and the highest score is 21.High scores indicate high levels of anxiety and depression
Time frame
Day 13
Comorbidity level
It will be evaluated with the Charlson Comorbidity Index. Total score is between 0-37. Higher scores indicate worse outcomes and higher risk of death.
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov